LCN2 and pancreatic adenocarcinoma: Recombinant LCN2 significantly promoted the phosphorylation levels of JAK2 and STAT3, but not of JAK1 and Tyk2, and increased CXCL1 levels in PAAD cells (Fig. 6c, Supplementary Fig. 20).